QuantaLife Wins $820K from NIH to Develop MRSA Test for Digital PCR Platform

QuantaLife has been awarded $820,000 in the first year of a five-year project with the University of Mississippi Medical Center to develop microdroplet PCR-based point-of-care tests to detect methicillin-resistant Staphylococcus aureus.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.